Treatment of Alzheimer's and Dementia With the Metabolism, Infections, Nutrition, Drug Elimination (MIND) Protocol
- Conditions
- Alzheimer's DiseaseDementia
- Interventions
- Other: A mix of natural treatments and medications
- Registration Number
- NCT02260167
- Lead Sponsor
- Practitioners Alliance Network
- Brief Summary
Treating with measures that may improve metabolic functioning of neurons in an integrated protocol
- Detailed Description
Most organ failure results in modest drops in function until over 50% of function is lost. At a certain point, even modest drops in physiologic activity result in dramatic drops in clinical function. Though less homogeneous than in other organs, clinical experience and the literature suggests a similar process occurs in the brain. The hypothesis is that by using an integrated protocol to, essentially, "tune up" neuronal function, a 5-10 % improvement in metabolic functioning may translate to significant improvement in clinical functioning. This tune-up will include "MIND":
M- Metabolism-- optimizing hormonal function I- Infections-- looking for and eliminating N- Nutritional and herbal support D- Drugs- Weaning subjects off unneeded medications
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 25
- A diagnosis of Alzheimer's and/or dementia with an MMSE score over 12 or being ambulatory and able to travel outside the home with assistance.
- Must have a caregiver living with them.
- Overt progressive and severe causes of secondary dementia such as metastatic brain cancers, or severe overt infectious encephalopathies or severe autoimmune illness.
- Also, severe life threatening illnesses which would make them unlikely to be alive after 6-12 months
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Treatment with MIND A mix of natural treatments and medications -
- Primary Outcome Measures
Name Time Method Montreal Cognitive Assessment (MoCA) 6 months Looking to see what percent of patients show improvement
- Secondary Outcome Measures
Name Time Method Mini Mental Status Exam (MMSE) 6 months Alzheimer's Disease Assessment Scale- Activities of Daily Living (ADAS-ADL) 6 months
Trial Locations
- Locations (1)
PAN
🇺🇸Kailua, Hawaii, United States